Please enter the keyword
WCH hosts Roundtable on Precision Medicine and Digital Health Innovation Development

On June 12, as a professional forum in the field of biomedicine at the 2nd Belt and Road Conference on Science and Technology Exchange, the Roundtable on Precision Medicine and Digital Health Innovation Development, co-hosted by the Sichuan Provincial Development and Reform Commission and West China Hospital WCH, Sichuan University and organized by the National Industrial Innovation Center of Precision MedicineNIIPCM, was held in Chengdu. Academician Wei Yuquan of the Chinese Academy of Sciences, Weerachai Arjiharn, Director General, Thailand Institute of Scientific and Technological Research (TISTR), Huang Zhi, Deputy Director General of the Sichuan Provincial Development and Reform Commission, Executive Vice President Huang Jin and Vice Presidents Wu Hong and Chen Lei of WCH, as well as nearly 100 domestic and international scholars, clinical experts, and corporate executives attended the meeting.

from clipboard from clipboard

Deputy Director General Huang Zhi and Executive Vice President Huang Jin delivered opening remarks, and Li Yuan, Director of the Scientific Research Laboratory Management Department of WCH and Executive Deputy Director of NIIPCM, presided over the meeting.

 from clipboard

Vice President Wu Hong, on behalf of the hospital, formally announced eight international cooperation projects to countries jointly building the Belt and Road Initiative, covering multiple fields such as liver minimally invasive technology, thoracoscopic surgery, and cutting-edge ultrasound technology.

 

Supamas Lisarabhakdi, Minister of Ministry of Higher Education, Science, Research and Innovation (MHESI) of Thailand, witnessed the signing ceremony between Chinese and Thai enterprises.

 

Three scientific and technological innovation achievements of WCH were also released on site: a lung cancer target gene mutation diagnostic kit (achieving precise and intelligent sequencing of lung cancer genes), a universal anti-tumor therapeutic cell vaccine (with innovative immunological principles and drug forms), and an intelligent and precise digital therapy for Parkinson's disease (a multimodal modeling digital biomarker system).